PFBT
PHAT icon

Parkside Financial Bank & Trust’s Phathom Pharmaceuticals PHAT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-85
Closed -$533 – 2936
2025
Q1 		$533 Buy
+85
New +$516 ﹤0.01% 2347

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Parkside Financial Bank & Trust's PHAT Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Phathom Pharmaceuticals (PHAT) in Q2 2025, closing a stake of 85 shares — an estimated $533 sold.

Parkside Financial Bank & Trust first reported a position in PHAT in Q1 2025 and held it in 1 quarter. The position peaked at $533 in Q1 2025. 117 funds tracked by Wall St. Rank hold PHAT as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Phathom Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 85 Phathom Pharmaceuticals shares in Q2 2025, an estimated $533.
  • Parkside Financial Bank & Trust first reported a position in Phathom Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Phathom Pharmaceuticals position peaked at $533 in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.